耐火性性直肠炎的管理
Manuel Barreiro-de Acosta1, Francisco Mesonero2, Rocío Ferreiro-Iglesias1
1Departamento de gastroenterología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España; Instituto de Investigaciones Sanitarias de Santiago (IDIS), España.
概括
耐火性性直肠炎 (RUP) 影响近30%的患者,显著影响生活质量. 本研究提供了RUP诊断和管理的实际建议,以解决知识差距.
科学领域:
- 胃肠病学 胃肠病学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性直肠炎 (UP) 通常遵循一个较温和的过程.
- 然而,有一小部分患者经历了显著的症状负担,严重的疾病或耐火性UP (RUP).
- 了解RUP对于改善患者的治疗结果至关重要.
研究的目的:
- 为了描述耐火性性直肠炎 (RUP).
- 为RUP的日常管理制定基于证据的建议.
- 解决RUP临床表现和治疗中的现有知识差距.
主要方法:
- 对43篇质量低至中等的文章进行了系统审查.
- 分析了RUP的流行病学,临床和药物治疗方面.
- 一个名义上的焦点组由胃肠科医生,一名护士和一名患者组成,讨论了研究结果和建议的管理陈述.
主要成果:
- 近30%的UP患者出现了RUP.
- RUP显著影响患者的生活质量.
- 确定了关于RUP特征,疾病过程和治疗疗效/安全的知识差距.
- 他们同意了关于RUP诊断,治疗目标,选择,监测和护理角色的13个实际陈述.
结论:
- 耐火性性直肠炎 (RUP) 是一种常见的疾病,对患者的福祉有重大影响.
- 需要进一步的研究,以充分描述RUP并评估长期治疗的疗效.
- 开发的陈述为管理RUP和填补当前知识缺口提供了实际指导.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
423
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
423
Peptic Ulcer Disease IV: Management
397
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
397
Drugs for Treatment of Ulcerative Colitis in IBD
416
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
416
Inflammatory Bowel Disease IV: Pharmacological Management
439
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
439
Peptic Ulcer Disease V: Surgical Management and Nursing Care
786
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
786
Drugs for Treatment of Constipation-Predominant IBS
670
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
670


